Mackenzie Financial
TGTX icon

Mackenzie Financial’s TG Therapeutics TGTX Stock Holding History

Mackenzie Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Hold
8,025
– – ﹤0.01% 1336
2026
Q2 		$441K Buy
+8,025
New +$328K ﹤0.01% 1347
2026
Q1 		– Sell
-9,101
Closed -$270K – 1749
2025
Q4 		$270K Sell
9,101
-441
-5% -$14.4K ﹤0.01% 1421
2025
Q3 		$345K Sell
9,542
-6,613
-41% -$218K ﹤0.01% 1362
2025
Q2 		$581K Buy
16,155
+568
+4% +$21.1K ﹤0.01% 1178
2025
Q1 		$615K Buy
15,587
+6,699
+75% +$225K ﹤0.01% 1132
2024
Q4 		$268K Sell
8,888
-7,609
-46% -$218K ﹤0.01% 1432
2024
Q3 		$386K Buy
16,497
+5,715
+53% +$125K ﹤0.01% 1091
2024
Q2 		$192K Hold
10,782
– – ﹤0.01% 1349
2024
Q1 		$164K Buy
+10,782
New +$172K ﹤0.01% 1372
2023
Q3 		– Sell
-18,788
Closed -$427K – 1593
2023
Q2 		$427K Buy
18,788
+6,053
+48% +$156K ﹤0.01% 1065
2023
Q1 		$192K Buy
+12,735
New +$193K ﹤0.01% 1353
2021
Q4 		– Sell
-7,487
Closed -$249K – 1498
2021
Q3 		$249K Buy
+7,487
New +$232K ﹤0.01% 1215
2020
Q4 		– Sell
-31,940
Closed -$855K – 1089
2020
Q3 		$855K Buy
+31,940
New +$735K ﹤0.01% 696

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Mackenzie Financial's TGTX Position: Q3 2026 in Review

Mackenzie Financial held its TG Therapeutics (TGTX) position steady in Q3 2026 at 8,025 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Mackenzie Financial first reported a position in TGTX in Q3 2020 and has held it in 14 quarters since. The position peaked at $855K in Q3 2020. 243 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Mackenzie Financial held 8,025 shares of TG Therapeutics worth $448K as of Q3 2026.
  • Mackenzie Financial left its TG Therapeutics share count unchanged in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1336 holding.
  • Mackenzie Financial first reported a position in TG Therapeutics in Q3 2020 and has held it in 14 quarters since.
  • Mackenzie Financial's TG Therapeutics position peaked at $855K in Q3 2020.
  • 243 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.